D'Amico TA - Search Results

1

Multi-institutional Care in Clinical Stage II and III Esophageal Cancer.

Rhodin KE, Raman V, Jensen CW, Kang L, Nussbaum DP, Tong BC, Blazer DG 3rd, D'Amico TA. Rhodin KE, et al. Ann Thorac Surg. 2023 Feb;115(2):370-377. doi: 10.1016/j.athoracsur.2022.06.049. Epub 2022 Jul 21. Ann Thorac Surg. 2023. PMID: 35872035 Free PMC article.

2

A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers.

D'Amico TA, Massey M, Herndon JE 2nd, Moore MB, Harpole DH Jr. D'Amico TA, et al. J Thorac Cardiovasc Surg. 1999 Apr;117(4):736-43. doi: 10.1016/s0022-5223(99)70294-1. J Thorac Cardiovasc Surg. 1999. PMID: 10096969 Free article.

3

Molecular biologic substaging of stage I lung cancer according to gender and histology.

D'Amico TA, Aloia TA, Moore MB, Herndon JE 2nd, Brooks KR, Lau CL, Harpole DH Jr. D'Amico TA, et al. Ann Thorac Surg. 2000 Mar;69(3):882-6. doi: 10.1016/s0003-4975(99)01522-2. Ann Thorac Surg. 2000. PMID: 10750777

4

Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients.

Lau CL, Palmer SM, Posther KE, Howell DN, Reinsmoen NL, Massey HT, Tapson VF, Jaggers JJ, D'Amico TA, Davis RD Jr. Lau CL, et al. Ann Thorac Surg. 2000 May;69(5):1520-4. doi: 10.1016/s0003-4975(00)01224-8. Ann Thorac Surg. 2000. PMID: 10881834

5

Tumor marker expression is predictive of survival in patients with esophageal cancer.

Aloia TA, Harpole DH Jr, Reed CE, Allegra C, Moore MB, Herndon JE 2nd, D'Amico TA. Aloia TA, et al. Ann Thorac Surg. 2001 Sep;72(3):859-66. doi: 10.1016/s0003-4975(01)02838-7. Ann Thorac Surg. 2001. PMID: 11565671

6

Predicting the sites of metastases from lung cancer using molecular biologic markers.

D'Amico TA, Aloia TA, Moore MB, Conlon DH, Herndon JE 2nd, Kinch MS, Harpole DH Jr. D'Amico TA, et al. Ann Thorac Surg. 2001 Oct;72(4):1144-8. doi: 10.1016/s0003-4975(01)02979-4. Ann Thorac Surg. 2001. PMID: 11603427

7

Thoracoscopic lobectomy: a safe and effective strategy for patients with stage I lung cancer.

Daniels LJ, Balderson SS, Onaitis MW, D'Amico TA. Daniels LJ, et al. Ann Thorac Surg. 2002 Sep;74(3):860-4. doi: 10.1016/s0003-4975(02)03764-5. Ann Thorac Surg. 2002. PMID: 12238851

8

Measurement of chemoresistance markers in patients with stage III non-small cell lung cancer: a novel approach for patient selection.

Brooks KR, To K, Joshi MB, Conlon DH, Herndon JE 2nd, D'Amico TA, Harpole DH Jr. Brooks KR, et al. Ann Thorac Surg. 2003 Jul;76(1):187-93; discussion 193. doi: 10.1016/s0003-4975(03)00131-0. Ann Thorac Surg. 2003. PMID: 12842538

9

Low morbidity and mortality for bronchoplastic procedures with and without induction therapy.

Burfeind WR Jr, D'Amico TA, Toloza EM, Wolfe WG, Harpole DH. Burfeind WR Jr, et al. Ann Thorac Surg. 2005 Aug;80(2):418-21; discussion 422. doi: 10.1016/j.athoracsur.2005.02.058. Ann Thorac Surg. 2005. PMID: 16039176

10

Outcomes of tracheobronchial stents in patients with malignant airway disease.

Lemaire A, Burfeind WR, Toloza E, Balderson S, Petersen RP, Harpole DH Jr, D'Amico TA. Lemaire A, et al. Ann Thorac Surg. 2005 Aug;80(2):434-7; discussion 437-8. doi: 10.1016/j.athoracsur.2005.02.071. Ann Thorac Surg. 2005. PMID: 16039180

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters